Algoritmo de tratamiento con omalizumab en urticaria crónica espontánea
- 1 November 2018
- journal article
- research article
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 109 (9) , 771-776
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled StudyJournal of Investigative Dermatology, 2015
- Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria controlJournal of Allergy and Clinical Immunology, 2014
- Retreatment With Omalizumab Results in Rapid Remission in Chronic Spontaneous and Inducible UrticariaJAMA Dermatology, 2014
- An algorithm for treating chronic urticaria with omalizumab: Dose interval should be individualizedJournal of Allergy and Clinical Immunology, 2014
- Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: A retrospective clinical analysisJournal of Dermatological Science, 2014
- Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapyJournal of Allergy and Clinical Immunology, 2013
- Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: analysis of 110 patients in real-life practiceExpert Opinion on Biological Therapy, 2013
- Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous UrticariaNew England Journal of Medicine, 2013
- Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1Allergy, 2010
- How to assess disease activity in patients with chronic urticaria?Allergy, 2008